On June 6, 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) ordered all federal lawsuits concerning testosterone replacement products (like AndroGel and Testim) be centralized into one court in the Northern District of Illinois. The panel determined that though some manufacturers have only a…
On July 1, 2014, CBS reported that a Mexican food truck had exploded in a northeast Philadelphia neighborhood, injuring thirteen people, two critically. Flames shot 200 feet into the air, with parts of the truck flying across the street. The Pittsburgh Post-Gazette later noted that…
Federal Judge Rebecca Doherty found that Takeda Pharmaceuticals acted in “bad faith” when it got rid of documents pertaining to Actos. Actos is used to treat Type 2 diabetes. In a June 2014 ruling, the “Court finds Takeda acted in bad faith as to the…
In April 2014, the FDA warned about the cancer risks associated with using power morcellation in uterine fibroid removal and hysterectomy procedures. Since then, many doctors have shied away from the technique, while a number of hospitals have stopped using the devices. Rather than completely…
A Pennsylvania judge signed an order on June 10, 2014 denying a motion to dismiss a case against Johnson & Johnson involving the wrongful death of an infant (No. 12-4162). Stacy Sherfey and Neil Sherfey, of Nevada, filed a complaint in 2012 alleging that their…
The Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee will come together on July 10th and 11th of 2014 to discuss the risks and benefits of power morcellation. One of those risks includes the potential for the power morcellator to spread cancerous…
Another Risperdal lawsuit has been filed due to serious side effects. Andrew Wasserman and his mother, Mary Wasserman, filed the complaint on June 12, 2014 against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals (3:14-cv-02739). Andrew allegedly developed breasts requiring a double mastectomy after using…
The FDA has received 22 report of serious adverse reactions, including death, among children and infants 5 months to 3.5 years of age that were given oral viscous lidocaine to treat teething pain. Now, the federal agency is requiring a boxed warning on those products.…
One of the founding partners at Chaffin Luhana is speaking out on blog talk radio this afternoon. Roopal Luhana will be talking about testosterone therapy lawsuits on MoneyForLunch Radio at 1:40mpm Central time. Right now our firm is investigating and litigating lawsuits on behalf of…
Manufacturers of testosterone therapy products will now include a more general warning on their labels about the risk of blood clots in the veins tied to the use of these drugs. Drug labels on approved testosterone therapy products already warned about the risk of “venous…
